{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:24:27Z","timestamp":1791606267258,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02866-9","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T14:03:07Z","timestamp":1713362587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of thymic stromal lymphopoietin in cutaneous disorders"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9452-3712","authenticated-orcid":false,"given":"Alexander J.","family":"Jafari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide A.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"issue":"1","key":"2866_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/EJI.1830260103","volume":"26","author":"RJ Ray","year":"1996","unstructured":"Ray RJ, Furlonger C, Williams DE, Paige CJ (1996) Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol 26(1):10\u201316. https:\/\/doi.org\/10.1002\/EJI.1830260103","journal-title":"Eur J Immunol"},{"issue":"7","key":"2866_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/NI805","volume":"3","author":"V Soumelis","year":"2002","unstructured":"Soumelis V, Reche PA, Kanzler H et al (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3(7):673\u2013680. https:\/\/doi.org\/10.1038\/NI805","journal-title":"Nat Immunol"},{"issue":"1","key":"2866_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","volume":"23","author":"R Ebina-Shibuya","year":"2023","unstructured":"Ebina-Shibuya R, Leonard WJ (2023) Role of thymic stromal lymphopoietin in allergy and beyond. Nat Rev Immunol 23(1):24\u201337. https:\/\/doi.org\/10.1038\/s41577-022-00735-y","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2866_CR4","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/J.CELL.2018.12.031","volume":"176","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi T, Voisin B, Kim DY et al (2019) Homeostatic control of sebaceous glands by innate lymphoid cells regulates commensal Bacteria equilibrium. Cell 176(5):982\u2013997e16. https:\/\/doi.org\/10.1016\/J.CELL.2018.12.031","journal-title":"Cell"},{"key":"2866_CR5","doi-asserted-by":"publisher","unstructured":"Verstraete K, Peelman F, Braun H et al (2017) Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma. Nat Commun 8. https:\/\/doi.org\/10.1038\/NCOMMS14937","DOI":"10.1038\/NCOMMS14937"},{"issue":"45","key":"2866_CR6","doi-asserted-by":"publisher","first-page":"19455","DOI":"10.1073\/PNAS.1008271107","volume":"107","author":"Y Rochman","year":"2010","unstructured":"Rochman Y, Kashyap M, Robinson GW et al (2010) Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling. Proc Natl Acad Sci U S A 107(45):19455\u201319460. https:\/\/doi.org\/10.1073\/PNAS.1008271107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2866_CR7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/JEM.20051135","volume":"202","author":"T Ito","year":"2005","unstructured":"Ito T, Wang YH, Duramad O et al (2005) TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 202(9):1213\u20131223. https:\/\/doi.org\/10.1084\/JEM.20051135","journal-title":"J Exp Med"},{"key":"2866_CR8","unstructured":"Flagnik M, Singh N, Holland S (2022) Paul\u2019s Fundamental Immunology, 8th edn. Lippincott Williams & Wilkins"},{"issue":"3","key":"2866_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1165\/RCMB.2008-0041OC","volume":"40","author":"M Harada","year":"2009","unstructured":"Harada M, Hirota T, Jodo AI et al (2009) Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol 40(3):368\u2013374. https:\/\/doi.org\/10.1165\/RCMB.2008-0041OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"2866_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/MI.2014.41","volume":"8","author":"L Bjerkan","year":"2015","unstructured":"Bjerkan L, Schreurs O, Engen SA et al (2015) The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide. Mucosal Immunol 8(1):49\u201356. https:\/\/doi.org\/10.1038\/MI.2014.41","journal-title":"Mucosal Immunol"},{"key":"2866_CR11","unstructured":"TSLP thymic stromal lymphopoietin [Homo sapiens (human)] - Gene - NCBI. NCBI. Published July 31, 2023. Accessed August 1 (2023) https:\/\/www.ncbi.nlm.nih.gov\/gene\/85480#gene-expression"},{"issue":"3","key":"2866_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.stemcr.2022.01.017","volume":"17","author":"JL Shannon","year":"2022","unstructured":"Shannon JL, Corcoran DL, Murray JC, Ziegler SF, MacLeod AS, Zhang JY (2022) Thymic stromal lymphopoietin controls hair growth. Stem Cell Rep 17(3):649\u2013663. https:\/\/doi.org\/10.1016\/j.stemcr.2022.01.017","journal-title":"Stem Cell Rep"},{"issue":"1","key":"2866_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/IMR.12546","volume":"278","author":"H Han","year":"2017","unstructured":"Han H, Roan F, Ziegler SF (2017) The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines. Immunol Rev 278(1):116\u2013130. https:\/\/doi.org\/10.1111\/IMR.12546","journal-title":"Immunol Rev"},{"issue":"133","key":"2866_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1183\/09059180.00004314","volume":"23","author":"M Li","year":"2014","unstructured":"Li M (2014) Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march. Eur Respir Rev 23(133):292\u2013298. https:\/\/doi.org\/10.1183\/09059180.00004314","journal-title":"Eur Respir Rev"},{"key":"2866_CR15","unstructured":"Atopic March Defined | AAAAI. American Academy of Allergy, Asthma & Immunology. Accessed August 1 (2023) https:\/\/www.aaaai.org\/tools-for-the-public\/allergy,-asthma-immunology-glossary\/atopic-march-defined"},{"key":"2866_CR16","doi-asserted-by":"publisher","unstructured":"Tsuge M, Ikeda M, Matsumoto N, Yorifuji T, Tsukahara H (2021) Current insights into atopic March. Child (Basel) 8(11). https:\/\/doi.org\/10.3390\/CHILDREN8111067","DOI":"10.3390\/CHILDREN8111067"},{"issue":"1","key":"2866_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/JID.2012.239","volume":"133","author":"JM Leyva-Castillo","year":"2013","unstructured":"Leyva-Castillo JM, Hener P, Jiang H, Li M (2013) TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice. J Invest Dermatol 133(1):154\u2013163. https:\/\/doi.org\/10.1038\/JID.2012.239","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2866_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/J.JAAD.2021.07.078","volume":"86","author":"N Sutaria","year":"2022","unstructured":"Sutaria N, Adawi W, Goldberg R, Roh YS, Choi J, Kwatra SG, Itch (2022) Pathogenesis and treatment. J Am Acad Dermatol 86(1):17\u201334. https:\/\/doi.org\/10.1016\/J.JAAD.2021.07.078","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2866_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1083\/JCB.201603042","volume":"213","author":"D Green","year":"2016","unstructured":"Green D, Dong X (2016) The cell biology of acute itch. J Cell Biol 213(2):155\u2013161. https:\/\/doi.org\/10.1083\/JCB.201603042","journal-title":"J Cell Biol"},{"issue":"3","key":"2866_CR20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1152\/PHYSREV.00017.2019","volume":"100","author":"F Cevikbas","year":"2020","unstructured":"Cevikbas F, Lerner EA (2020) Physiology and pathophysiology of itch. Physiol Rev 100(3):945\u2013982. https:\/\/doi.org\/10.1152\/PHYSREV.00017.2019","journal-title":"Physiol Rev"},{"issue":"3","key":"2866_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/S12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt A, Chiricozzi A (2018) The immunologic role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis. Clin Rev Allergy Immunol 55(3):379\u2013390. https:\/\/doi.org\/10.1007\/S12016-018-8702-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"2866_CR22","doi-asserted-by":"publisher","unstructured":"Li SZ, Jin XX, Shan Y, Jin HZ, Zuo YG (2022) Expression of Thymic Stromal Lymphopoietin in Immune-related dermatoses. Mediators Inflamm 2022. https:\/\/doi.org\/10.1155\/2022\/9242383","DOI":"10.1155\/2022\/9242383"},{"issue":"1","key":"2866_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/J.1365-2133.2011.10610.X","volume":"166","author":"BF Chong","year":"2012","unstructured":"Chong BF, Song J, Olsen NJ (2012) Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus. Br J Dermatol 166(1):29\u201335. https:\/\/doi.org\/10.1111\/J.1365-2133.2011.10610.X","journal-title":"Br J Dermatol"},{"issue":"4","key":"2866_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/S40265-022-01679-2","volume":"82","author":"SM Hoy","year":"2022","unstructured":"Hoy SM, Tezepelumab (2022) First approval. Drugs 82(4):461\u2013468. https:\/\/doi.org\/10.1007\/S40265-022-01679-2","journal-title":"Drugs"},{"issue":"4","key":"2866_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/J.JAAD.2018.11.059","volume":"80","author":"EL Simpson","year":"2019","unstructured":"Simpson EL, Parnes JR, She D et al (2019) Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: a randomized phase 2a clinical trial. J Am Acad Dermatol 80(4):1013\u20131021. https:\/\/doi.org\/10.1016\/J.JAAD.2018.11.059","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2866_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/S40257-022-00683-2","volume":"23","author":"A Blauvelt","year":"2022","unstructured":"Blauvelt A, Guttman-Yassky E, Paller AS et al (2022) Long-term efficacy and safety of Dupilumab in adolescents with moderate-to-severe atopic dermatitis: results through Week 52 from a phase III open-label extension Trial (LIBERTY AD PED-OLE). Am J Clin Dermatol 23(3):365\u2013383. https:\/\/doi.org\/10.1007\/S40257-022-00683-2","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"2866_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/S13555-021-00657-Y","volume":"12","author":"A Blauvelt","year":"2022","unstructured":"Blauvelt A, de Bruin-Weller M, Simpson EL, Chen Z, Ardeleanu M, Rossi AB (2022) Consistency of response to Dupilumab in adults with moderate-to-severe atopic Dermatitis over 1 year. Dermatol Ther (Heidelb) 12(1):9\u201313. https:\/\/doi.org\/10.1007\/S13555-021-00657-Y","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"2866_CR28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/S12016-017-8620-9","volume":"54","author":"RM Tr\u00fceb","year":"2018","unstructured":"Tr\u00fceb RM, Dias MFRG (2018) Alopecia Areata: a Comprehensive Review of Pathogenesis and Management. Clin Rev Allergy Immunol 54(1):68\u201387. https:\/\/doi.org\/10.1007\/S12016-017-8620-9","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"2866_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/EXD.14254","volume":"30","author":"Y Gong","year":"2021","unstructured":"Gong Y, Luo L, Li L et al (2021) Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP\/OX40L\/IL-13 pathway in severe Alopecia Areata. Exp Dermatol 30(2):278\u2013283. https:\/\/doi.org\/10.1111\/EXD.14254","journal-title":"Exp Dermatol"},{"issue":"3","key":"2866_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/J.CLINDERMATOL.2014.12.001","volume":"33","author":"ND Hill","year":"2015","unstructured":"Hill ND, Bunata K, Hebert AA (2015) Treatment of Alopecia Areata with squaric acid dibutylester. Clin Dermatol 33(3):300\u2013304. https:\/\/doi.org\/10.1016\/J.CLINDERMATOL.2014.12.001","journal-title":"Clin Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02866-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T09:46:30Z","timestamp":1717494390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02866-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["2866"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02866-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reprint requests"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}